China SXT Pharmaceuticals Inc (SXTC) — Net Asset Quality Index
China SXT Pharmaceuticals Inc (SXTC) has a Net Asset Quality Index of 76.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $26.35 Million minus total liabilities of $6.12 Million yields net assets of $20.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of China SXT Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
China SXT Pharmaceuticals Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how China SXT Pharmaceuticals Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of September 2025, the index stands at 76.8%, representing net assets of $20.23 Million against total assets of $26.35 Million USD. See China SXT Pharmaceuticals Inc (SXTC) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for China SXT Pharmaceuticals Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for China SXT Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of China SXT Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.3% | $15.44 Million | $21.66 Million | $6.22 Million | ▲ +11.0 pp |
| 2024 | 60.2% | $13.93 Million | $23.13 Million | $9.20 Million | ▲ +10.5 pp |
| 2023 | 49.7% | $14.69 Million | $29.55 Million | $14.86 Million | ▲ +0.7 pp |
| 2022 | 49.0% | $16.42 Million | $33.55 Million | $17.12 Million | ▲ +2.8 pp |
| 2021 | 46.2% | $15.96 Million | $34.55 Million | $18.59 Million | ▲ +2.9 pp |
| 2020 | 43.3% | $9.40 Million | $21.70 Million | $12.30 Million | ▼ -20.3 pp |
| 2019 | 63.6% | $11.11 Million | $17.47 Million | $6.36 Million | ▲ +20.7 pp |
| 2018 | 42.9% | $3.29 Million | $7.66 Million | $4.37 Million | ▲ +8.8 pp |
| 2017 | 34.1% | $1.85 Million | $5.43 Million | $3.58 Million | ▲ +22.3 pp |
| 2016 | 11.8% | $742.77K | $6.30 Million | $5.55 Million | — |